by Steven Ertelt
November 21, 2007
Washington, DC (LifeNews.com) — Dozens of pro-life groups have emailed LifeNews.com showing their approval for a new embryonic stem cell research method that allows scientists to obtain the versatile cells without the destruction of human life. They say the method has the potential of radically changing the stem cell research debate.
Below is a sampling of some of the pro-life groups and leaders who have contacted LifeNews.com with their take on the new method.
Tony Perkins, Family Research Council President: "Yamanaka and Thomson are to be congratulated for pushing forward the frontiers of science and demonstrating that good science can also satisfy ethical requirements. Coupled with the recent announcement by Dr. Ian Wilmut, cloner of Dolly the sheep, that he is shelving cloning as an unproductive technique in favor of this new ethical method, dubious experiments involving embryo cloning and embryo destruction are being rendered obsolete."
Cardinal Justin Rigali of Philadelphia, chairman of the Committee for Pro-Life Activities at the United States Conference of Catholic Bishops: "This technology avoids the many ethical landmines associated with embryonic stem cell research: it does not clone or destroy human embryos, does not harm or exploit women for their eggs, and does not blur the line between human beings and other species through desperate efforts to make human embryos using animal eggs."
"Once again science is catching up to ethics, proving that the moral way is the most sound, scientific choice. This breakthrough allows scientists to further their research and continue to develop medical advances while still honoring the sanctity of life" said Wendy Wright, President of Concerned Women for America.
Americans United for Life president Clarke Forsythe: "This tremendous breakthrough is both ethically and scientifically sound."
Mary Kay Culp, Executive Director of Kansans for Life: This ought to cause a sea change in public policy in Missouri and Kansas. Whether or not it does depends on the willingness of organizations like Stowers to choose this ethical alternative to the human cloning research in which they are so heavily invested."